文献速递糖尿病

ATLANTIC DIP:胰岛素治疗国际糖尿病与妊娠研究组标准诊断的妊娠期糖尿病是否有效

ATLANTIC DIP: Insulin Therapy for Women With IADPSG-Diagnosed Gestational Diabetes Mellitus. Does It Work?
PubMed 文献 · J Clin Endocrinol Metab · 2017-01-01

该回顾性队列研究纳入752例胰岛素治疗的妊娠期糖尿病(GDM)孕妇和2496例血糖正常(NGT)孕妇,比较母婴结局。胰岛素治疗的GDM孕妇的巨大的儿、大于胎龄儿、小于胎龄儿及母体高血压性疾病发生率与NGT孕妇相似,但新生儿低血糖和羊水过多风险仍较高,新生儿重症监护病房入住率更高且主要因非医学原因。

要点

  • 胰岛素治疗的GDM孕妇的巨大儿、大于胎龄儿、小于胎龄儿发生率与NGT孕妇无显著差异。
  • GDM组新生儿低血糖(aOR 6.85)和新生儿重症监护病房入住(aOR 12.09)风险显著高于NGT组。
  • GDM组羊水过多风险显著升高(aOR 7.75),但妊娠期高血压疾病和出血风险与NGT组相似。

核心结论

  • 胰岛素治疗IADPSG标准诊断的GDM可使巨大的儿、大于胎龄儿、小于胎龄儿及母体高血压性疾病发生率与NGT孕妇相似,但新生儿低血糖和羊水过多仍较高,NICU入住增多主要因非医学原因。

研究设计与样本

  • 回顾性队列研究,纳入752例胰岛素治疗的GDM孕妇和2496例NGT孕妇,比较母婴结局。

主要发现

  • 胰岛素治疗的GDM组与NGT组相比,巨大的儿aOR 1.19(95%CI 0.87-1.63,P=0.26)、大于胎龄儿aOR 1.07(95%CI 0.77-1.47,P=0.67)、小于胎龄儿aOR 0.70(95%CI 0.38-1.38,P=0.26),均无显著差异。
  • GDM组新生儿低血糖风险显著高于NGT组(aOR 6.85,95%CI 2.31-20.28,P<0.01),NICU入住风险显著高于NGT组(aOR 12.09,95%CI 8.72-16.76,P<0.01),主要因非医学原因。
  • GDM组羊水过多风险显著高于NGT组(aOR 7.75,95%CI 3.96-15.16,P<0.01)。
  • 两组子痫前期(aOR 0.64,95%CI 0.34-1.12,P=0.17)、妊娠期高血压(aOR 1.11,95%CI 0.74-1.66,P=0.60)、产前出血(aOR 0.56,95%CI 0.19-1.58,P=0.27)和产后出血(aOR 1.17,95%CI 0.68-2.03,P=0.55)风险均无显著差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Approximately 40% of women with gestational diabetes mellitus (GDM) diagnosed using International Association of the Diabetes and Pregnancy Study Group (IADPSG) criteria require insulin therapy. OBJECTIVE: We assessed whether the outcomes for women with GDM treated with insulin are comparable to women with normal glucose tolerance (NGT). MATERIALS AND METHODS: This retrospective cohort study included 752 women with insulin-treated GDM and 2496 women with NGT during pregnancy. Maternal and fetal outcomes were examined. RESULTS: Infants of women with insulin-treated GDM had rates of macrosomia [adjusted odds ratio (aOR), 1.19; 95% confidence interval (CI), 0.87 to 1.63; P = 0.26], large for gestational age (LGA) (aOR, 1.07; 95% CI, 0.77 to 1.47; P = 0.67), and small for gestational age (SGA) (aOR, 0.70; 95% CI, 0.38 to 1.38; P = 0.26) similar to women with NGT. They were more likely to be hypoglycemic at birth (aOR, 6.85; 95% CI, 2.31 to 20.28; P < 0.01) and to require neonatal intensive care unit care (NICU) (aOR, 12.09; 95% CI, 8.72 to 16.76; P < 0.01), predominantly for nonmedical reasons. Maternal rates of hypertensive disorders (preeclampsia: aOR, 0.64; 95% CI, 0.34 to 1.12; P = 0.17; pregnancy-induced hypertension: aOR, 1.11; 95% CI, 0.74 to 1.66; P = 0.60) and hemorrhage (ante partum hemorrhage: aOR, 0.56; 95% CI, 0.19 to 1.58; P = 0.27; postpartum hemorrhage: aOR, 1.17; 95% CI, 0.68 to 2.03; P = 0.55) were similar between groups, but the risk of polyhydramnios was increased in the GDM cohort (aOR, 7.75; 95% CI, 3.96 to 15.16; P < 0.01). CONCLUSIONS: Insulin treatment of IADPSG-diagnosed GDM results in rates of macrosomia, LGA, SGA, and maternal hypertensive disorders similar to those of women with NGT. Although NICU admissions are greater in the GDM cohort, they are primarily for nonmedical reasons. Neonatal hypoglycemia and polyhydramnios remain greater among women with insulin-treated GDM.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Bogdanet D, Egan AM, Reddin C, et al. ATLANTIC DIP: Insulin Therapy for Women With IADPSG-Diagnosed Gestational Diabetes Mellitus. Does It Work? J Clin Endocrinol Metab. 2017. PMID: 27901638. doi:10.1210/jc.2016-2911

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。